Publications by authors named "Nicholas Verity"

Claim this Profile
C
Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease.
Barry M Bradford, Lauryn Walmsley-Rowe, Joe Reynolds, Nicholas Verity, Neil A Mabbott

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome.
Sang S Seo, Susana R Louros, Natasha Anstey, Miguel A Gonzalez-Lozano, Callista B Harper, Nicholas C Verity

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TrkB signaling regulates the cold-shock protein RBM3-mediated neuroprotection.
Diego Peretti, Heather L Smith, Nicholas Verity, Ibrahim Humoud, Lis de Weerd

Life Sci Alliance· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the kinase insert loop of PERK selectively modulates PERK signaling without systemic toxicity in mice.
Daniel T Hughes, Mark Halliday, Heather L Smith, Nicholas C Verity, Colin Molloy

Sci Signal· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Astrocyte Unfolded Protein Response Induces a Specific Reactivity State that Causes Non-Cell-Autonomous Neuronal Degeneration.
Heather L Smith, Oliver J Freeman, Adrian J Butcher, Staffan Holmqvist, Ibrahim Humoud, Nicholas C Verity

Neuron· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.
Mark Halliday, Helois Radford, Karlijn A M Zents, Collin Molloy, Julie A Moreno, Nicholas C Verity

Brain· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss.
Sophie J Bradley, Julie-Myrtille Bourgognon, Helen E Sanger, Nicholas Verity, Adrian J Mogg

J Clin Invest· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
Helois Radford, Julie A Moreno, Nicholas Verity, Mark Halliday, Giovanna R Mallucci

Acta Neuropathol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration.
Diego Peretti, Amandine Bastide, Helois Radford, Nicholas Verity, Colin Molloy

Nature· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice.
Julie A Moreno, Mark Halliday, Colin Molloy, Helois Radford, Nicholas Verity

Sci Transl Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained translational repression by eIF2α-P mediates prion neurodegeneration.
Julie A Moreno, Helois Radford, Diego Peretti, Joern R Steinert, Nicholas Verity

Nature· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescuing neurons in prion disease.
Nicholas C Verity, Giovanna R Mallucci

Biochem J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis